Plain and contrast‑enhanced chest computed tomography scan findings of pulmonary cryptococcosis in immunocompetent patients

Yang,Rongshui; Yan,Yan; Wang,Yuhuan; Liu,Xiaohuan; Su,Xinhui

doi:10.3892/etm.2017.5096

Plain and contrast‑enhanced chest computed tomography scan findings of pulmonary cryptococcosis in immunocompetent patients

Authors:
- Rongshui Yang
- Yan Yan
- Yuhuan Wang
- Xiaohuan Liu
- Xinhui Su
View Affiliations

Affiliations: Department of Radiology, Xinglin Branch Hospital, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, P.R. China, Department of Pathology, The First Affiliated Hospital of Xiamen University, Xiamen, Fujian 361003, P.R. China, Department of Nuclear Medicine, Zhongshan Hospital, Xiamen University, Xiamen, Fujian 361004, P.R. China
Published online on: September 1, 2017 https://doi.org/10.3892/etm.2017.5096
Pages: 4417-4424

Metrics: Total Views: 0 (Spandidos Publications: | PMC Statistics: )

Metrics: Total PDF Downloads: 0 (Spandidos Publications: | PMC Statistics: )

Cited By (CrossRef): 0 citations Loading Articles...

Abstract

Pulmonary cryptococcosis is most commonly reported in immunocompromised patients, whereas immunocompetent hosts are rarely affected and may be asymptomatic, resulting in reduced diagnostic performance of computed tomography (CT) imaging. Thus, the aim of the present study was to review the plain and contrast‑enhanced chest CT scan findings of primary pulmonary cryptococcosis in immunocompetent patients, with the aim of improving the diagnosis of this type of pulmonary disease. In the present study, a total of 27 immunocompetent patients of clinically confirmed pulmonary cryptococcosis were analyzed retrospectively. Of the 27 patients, 14 patients underwent plain and contrast‑enhanced chest CT scans, while 13 patients only underwent plain chest CT scanning. The clinical and imaging characteristics, including the location, shape, size, number, edge and attenuation or intensity of each lesion, in unenhanced and contrast‑enhanced CT scans were reviewed. The results indicated that the most common CT finding was pulmonary nodules (40.74%), with multiple nodules (25.93%) being more common compared with solitary nodules (14.81%). The majority of the nodules were poorly defined and inhomogeneous with observed air‑bubble sign. Other findings included consolidation (25.93%), ground‑glass opacities (GGO; 22.22%) and a mass (11.11%). The halo, air bronchogram and cavity signs were observed more frequently (22.22, 18.52 and 14.81%, respectively). The pulmonary lesions presented a predominant distribution in the lower lung lobes and peripheral area in 55.55 and 74.07% of the cases, respectively. On the contrast‑enhanced CT images, the majority of nodules presented ring enhancement with the mean maximal enhancement value of 20.92±5.67 Hu, and masses demonstrated inhomogeneous enhancement with a mean maximal enhancement value of 35.61±8.32 Hu. In conclusion, familiarity with the CT findings and occupational environment exposure history will assist in earlier and easier diagnosis of pulmonary cryptococcosis in immunocompetent patients.

View Figures

View References

1	Smith IM, Stephan C, Hogardt M, Klawe C, Tintelnot K and Rickerts V: Cryptococcosis due to Cryptococcus gattii in Germany from 2004–2013. Int J Med Microbiol. 305:719–723. 2015. View Article : Google Scholar : PubMed/NCBI
2	Teodoro VL, Gullo FP, Sardi Jde C, Torres EM, Fusco-Almeida AM and Mendes-Giannini MJ: Environmental isolation, biochemical identification, and antifungal drug susceptibility of Cryptococcus species. Rev Soc Bras Med Trop. 46:759–764. 2013. View Article : Google Scholar : PubMed/NCBI
3	Fang W, Fa Z and Liao W: Epidemiology of Cryptococcus and cryptococcosis in China. Fungal Genet Biol. 78:7–15. 2015. View Article : Google Scholar : PubMed/NCBI
4	Yamakawa H, Yoshida M, Yabe M, Baba E, Okuda K, Fujimoto S, Katagi H, Ishikawa T, Takagi M and Kuwano K: Correlation between clinical characteristics and chest computed tomography findings of pulmonary cryptococcosis. Pulm Med. 2015:7034072015. View Article : Google Scholar : PubMed/NCBI
5	Alanio A, Desnos-Ollivier M and Dromer F: Dynamics of Cryptococcus neoformans-macrophage interactions reveal that fungal background influences outcome during cryptococcal meningoencephalitis in humans. MBio. 2(4): e00158–11. 2011. View Article : Google Scholar : PubMed/NCBI
6	Schelenz S, Barnes RA, Barton RC, Cleverley JR, Lucas SB, Kibbler CC and Denning DW: British Society for Medical Mycology: British Society for Medical Mycology best practice recommendations for the diagnosis of serious fungal diseases. Lancet Infect Dis. 15:461–474. 2015. View Article : Google Scholar : PubMed/NCBI
7	Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, et al: Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of america. Clin Infect Dis. 50:291–322. 2010. View Article : Google Scholar : PubMed/NCBI
8	Sider L and Westcott MA: Pulmonary manifestations of cryptococcosis in patients with AIDS: CT features. J Thorac Imaging. 9:78–84. 1994. View Article : Google Scholar : PubMed/NCBI
9	Brizendine KD, Baddley JW and Pappas PG: Predictors of mortality and differences in clinical features among patients with cryptococcosis according to immune status. PLoS One. 8:e604312013. View Article : Google Scholar : PubMed/NCBI
10	Kishi K, Homma S, Kurosaki A, Kohno T, Motoi N and Yoshimura K: Clinical features and high-resolution CT findings of pulmonary cryptococcosis in non-AIDS patients. Respir Med. 100:807–812. 2006. View Article : Google Scholar : PubMed/NCBI
11	Fox DL and Müller NL: Pulmonary cryptococcosis in immunocompetent patients: CT findings in 12 patients. AJR Am J Roentgenol. 185:622–626. 2005. View Article : Google Scholar : PubMed/NCBI
12	Espinel-Ingroff A and Kidd SE: Current trends in the prevalence of Cryptococcus gattii in the United States and Canada. Infect Drug Resist. 8:89–97. 2015. View Article : Google Scholar : PubMed/NCBI
13	Guarner J and Brandt ME: Histopathologic diagnosis of fungal infections in the 21st century. Clin Microbiol Rev. 24:247–280. 2011. View Article : Google Scholar : PubMed/NCBI
14	Barton RC: Laboratory diagnosis of invasive aspergillosis: From diagnosis to prediction of outcome. Scientifica (Cairo). 2013:4594052013.PubMed/NCBI
15	Ye XD, Ye JD, Yuan Z, Li WT and Xiao XS: Dynamic CT of solitary pulmonary nodules: Comparison of contrast medium distribution characteristic of malignant and benign lesions. Clin Transl Oncol. 16:49–56. 2014. View Article : Google Scholar : PubMed/NCBI
16	Feng X, Yao Z, Ling B, et al: Analysis of the varieties, genotypes and mating types of 110 clinical cryptococcal isolates from China. Chin J Microbiol Immunol. 28:193–197. 2008.
17	Wu SY, Lei Y, Kang M, Xiao YL and Chen ZX: Molecular characterisation of clinical Cryptococcus neoformans Cryptococcus gattii isolates from Sichuan province, China. Mycoses. 58:280–287. 2015. View Article : Google Scholar : PubMed/NCBI
18	Galanis E, Macdougall L, Kidd S and Morshed M: British Columbia Cryptococcus gattii Working Group: Epidemiology of Cryptococcus gattii, British Columbia, Canada, 1999–2007. Emerg Infect Dis. 16:251–257. 2010. View Article : Google Scholar : PubMed/NCBI
19	Xie X, Xu B, Yu C, Chen M, Yao D, Xu X, Cai X, Ding C, Wang L and Huang X: Clinical analysis of pulmonary cryptococcosis in non-HIV patients in south China. Int J Clin Exp Med. 8:3114–3119. 2015.PubMed/NCBI
20	Xie LX, Chen YS, Liu SY and Shi YX: Pulmonary cryptococcosis: Comparison of CT findings in immunocompetent and immunocompromised patients. Acta Radiol. 56:447–453. 2015. View Article : Google Scholar : PubMed/NCBI
21	Yuchong C, Fubin C, Jianghan C, Fenglian W, Nan X, Minghui Y, Yalin S and Zhizhong Z: Cryptococcosis in China (1985–2010): Review of cases from Chinese database. Mycopathologia. 173:329–335. 2012. View Article : Google Scholar : PubMed/NCBI
22	Chen YY and Lai CH: Nationwide population-based epidemiologic study of cryptococcal meningitis in Taiwan. Neuroepidemiology. 36:79–84. 2011. View Article : Google Scholar : PubMed/NCBI
23	Zhang Y, Li N, Zhang Y, Li H, Chen X, Wang S, Zhang X, Zhang R, Xu J, Shi J and Yung RC: Clinical analysis of 76 patients pathologically diagnosed with pulmonary cryptococcosis. Eur Respir J. 40:1191–1200. 2012. View Article : Google Scholar : PubMed/NCBI
24	Charlier C, Nielsen K, Daou S, Brigitte M, Chretien F and Dromer F: Evidence of a role for monocytes in dissemination and brain invasion by Cryptococcus neoformans. Infect Immun. 77:120–127. 2009. View Article : Google Scholar : PubMed/NCBI
25	Sorrell TC, Juillard PG, Djordjevic JT, Kaufman-Francis K, Dietmann A, Milonig A, Combes V and Grau GE: Cryptococcal transmigration across a model brain blood-barrier: Evidence of the Trojan horse mechanism and differences between Cryptococcus neoformans var. Grubii strain H99 and Cryptococcus gattii strain R265. Microbes Infect. 18:57–67. 2016. View Article : Google Scholar : PubMed/NCBI
26	Lee WY, Wu JT, Jeng CM, HSU CY, Liu JS, Wang YC, Wu CY, Chang HY, Huang JC, Yang CM and Kung CH: CT Findings of pulmonary cryptococcosis: A series of 12 cases. Chin J Radiol. 30:319–325. 2005.
27	Ye F, Xie JX, Zeng QS, Chen GQ, Zhong SQ and Zhong NS: Retrospective analysis of 76 immunocompetent patients with primary pulmonary cryptococcosis. Lung. 190:339–346. 2012. View Article : Google Scholar : PubMed/NCBI
28	Lindell RM, Hartman TE, Nadrous HF and Ryu JH: Pulmonary cryptococcosis: CT findings in immunocompetent patients. Radiology. 236:326–331. 2005. View Article : Google Scholar : PubMed/NCBI
29	Zinck SE, Leung AN, Frost M, Berry GJ and Müller NL: Pulmonary Cryptococcosis: CT and Pathologic Findings. J Comput Assist Tomogr. 26:330–334. 2002. View Article : Google Scholar : PubMed/NCBI
30	Lee YR, Choi YW, Lee KJ, Jeon SC, Park CK and Heo JN: CT halo sign: The spectrum of pulmonary diseases. Br J Radiol. 78:862–865. 2005. View Article : Google Scholar : PubMed/NCBI
31	Chang WC, Tzao C, Hsu HH, Lee SC, Huang KL, Tung HJ and Chen CY: Pulmonary cryptococcosis: Comparison of clinical and radiographic characteristics in immunocompetent andimmunocompromised patients. Chest. 129:333–340. 2006. View Article : Google Scholar : PubMed/NCBI
32	Saag MS, Graybill RJ, Larsen RA, Pappas PG, Perfect JR, Powderly WG, Sobel JD and Dismukes WE: Practice guidelines for the management of cryptococcal disease. Infectious Diseases Society of America. Clin Infect Dis. 30:710–718. 2000. View Article : Google Scholar : PubMed/NCBI
33	Perfect JR, Dismukes WE, Dromer F, Goldman DL, Graybill JR, Hamill RJ, Harrison TS, Larsen RA, Lortholary O, Nguyen MH, et al: Clinical practice guidelines for the management of cryptococcal disease: 2010 update by the infectious diseases society of America. Clin Infect Dis. 50:291–322. 2010. View Article : Google Scholar : PubMed/NCBI